ContraFect Provides Program Update
06 janv. 2017 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - January 06, 2017) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at Biotech Showcase 2017 Conference
04 janv. 2017 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - January 04, 2017) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at 28th Annual Piper Jaffray Healthcare Conference
23 nov. 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 23, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Awarded $2.1 Million PRMRP Grant to Support Development of CF-301
17 nov. 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 17, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Announces Expanded Research Collaboration with The Rockefeller University to Identify Lysin Therapeutics Targeting Gram-negative Bacteria
14 nov. 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 14, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at The Lysin Meeting
10 nov. 2016 16h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 10, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Reports Third Quarter 2016 Financial Results and Provides Business Update
09 nov. 2016 16h30 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Announces Second Quarter 2016 Results
09 août 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY --(Marketwired - August 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency
04 août 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - August 04, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Presents New CF-301 Data at ASM Microbe 2016
21 juin 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - June 21, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...